Key facts
- This page summarizes Richard J. Daly's Form 3 filing for Aquestive Therapeutics, Inc. (AQST).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 16 Oct 2026, 13:58.
Richard J. Daly - 15 Oct 2026 Form 3 Insider Report for Aquestive Therapeutics, Inc. (AQST)
- Reporting relationship
- Director
- Issuer ticker
- AQST
- Reported as of
- 15 Oct 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 16 Oct 2026, 13:58:28 UTC
- Prior SEC filing
- 17 Jul 2026
- Next SEC filing
- 10 Nov 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas Zalewski, as Attorney-In-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Richard J. Daly filed Form 3 for Aquestive Therapeutics, Inc. (AQST) on 16 Oct 2026.
Change
- Previous filing in this sequence was filed on 17 Jul 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001635393
Primary reporting owner
Daly Richard J
- Relationship
- Director
- Address
- C/O AQUESTIVE THERAPEUTICS, INC., 184 LIBERTY CORNER DRIVE, SUITE 305, WARREN
- Signature
- /s/ Thomas Zalewski, as Attorney-In-Fact
- Signature date
- 16 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AQST
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 15 Oct 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.